India Glycols

    INDIAGLYCO
    FMCG
    ₹271.75
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹1,821 Cr

    P/E
    5.50
    Day range
    ₹268.05 – ₹279.00
    52-week range
    ₹217.00 – ₹1,222.00
    Volume
    4.14 L
    Open
    ₹272.50
    Prev close
    ₹275.05

    Latest results · Q2 FY27(consolidated)Revenue ₹362 Cr-85.0%Profit ₹24 Cr-63.6%Margin 6.5%YoY vs the same quarter last year

    No red flags in exchange filings: no rising pledge, promoter selling, surveillance or critical filing on record.

    Research profile

    Factor percentiles

    Value72
    Quality45
    Momentum—
    Low volatility—

    Derived metrics

    Earn. yield
    18.2%
    Graham no.
    ₹637.97
    vs Graham
    +134.8%
    ROE ÷ P/B
    15.9%
    Magic Formula
    #167
    Piotroski
    5/6
    FCF yield
    -3.0%
    PEG
    0.15

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 45 in FMCG
    Largest FMCG companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Hindustan UnileverHINDUNILVR₹4.68 L Cr44.259.5830.7%28.0%22.0%0.03+14.5%
    ITCITC₹3.72 L Cr19.685.1829.5%39.0%28.0%0.01+3.9%
    Nestle IndiaNESTLEIND₹2.47 L Cr60.6043.2376.3%85.0%24.0%0.08+20.3%
    Varun BeveragesVBL₹1.44 L Cr146.907.4316.9%20.0%22.0%0.13+33.2%
    MaricoMARICO₹1.18 L Cr58.2325.1144.3%47.0%18.0%0.26+13.0%
    Britannia IndustriesBRITANNIA₹1.13 L Cr42.1526.9953.6%56.0%18.0%0.62+15.6%
    Tata Consumer ProductsTATACONSUM₹1.12 L Cr65.864.997.4%9.0%14.0%0.11+14.0%
    India GlycolsINDIAGLYCO₹1,821 Cr5.500.7111.3%12.0%15.0%0.58+8.7%
    Sector median₹14,559 Cr34.445.4818.1%19.0%15.0%0.20+14.8%

    Sector as classified in the tracked universe; medians use every tracked FMCG company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 3h ago

    Headlines about India Glycols from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    8.6
    Price / Book
    1.45
    ROE (FY26)
    11.3%
    ROCE (latest year)
    12%
    Dividend yield
    2.76%

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +16.7%
    Profit 3Y CAGR
    +27.6%
    Revenue YoY (Sep 2026)
    -66.8%
    Profit YoY (Sep 2026)
    -63.1%
    Operating margin
    11.0%
    Net margin
    6.6%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr500 Cr1K Cr1.5K Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%9%18%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • Public
    • DII
    • FII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-1K Cr-500 Cr0 Cr500 Cr1K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%10%20%30%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr1K Cr2K Cr3K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 20260x1x2x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date. Not adjusted for the split of 12 Aug 2025: earlier bars are per pre-split share.

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26₹0₹5₹10₹15

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales9049269699619758631,0401,0921,102976357362
    YoY Sales growth—————-7————-66-67
    Expenses802822843845852717891935927810318324
    Operating Profit1021051261161241461501581751663939
    OPM %11%11%13%12%13%17%14%14%16%17%11%11%
    Other Income9101415191320143142113
    Interest313336404445454947261212
    Depreciation262628282733343841411212
    Profit before tax5456766371829184911123728
    Tax %23%24%20%22%20%22%19%22%25%23%11%14%
    Net Profit424260505764736568873324
    EPS in Rs₹6.71₹6.81₹9.74₹8.02₹9.16₹10.33₹11.81₹10.51₹10.09₹12.97₹4.86₹3.54

    From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days30

    -27 days since Mar 2021

    Inventory Days139

    -27 days since Mar 2021

    Days Payable123

    -35 days since Mar 2021

    Cash Conversion Cycle47

    -18 days since Mar 2021

    Working Capital Days-49

    +30 days since Mar 2021

    Strengths, risks & growth

    Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1] [2]

    Strengths

    • Company has reduced debt.

    Risks

    • Company has a low return on equity of 10.4% over last 3 years.
    • Company's cost of borrowing seems high

    Compounded Sales Growth

    10 Years
    +6%
    5 Years
    +13%
    3 Years
    +17%
    TTM
    -30%

    Compounded Profit Growth

    10 Years
    +74%
    5 Years
    +14%
    3 Years
    +39%
    TTM
    -18%

    Stock Price CAGR

    10 Years
    +36%
    5 Years
    +24%
    3 Years
    +53%
    1 Year
    +14%

    Return on Equity

    10 Years
    +10%
    5 Years
    +10%
    3 Years
    +10%
    Last Year
    +11%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter59.63%59.63%59.63%59.63%0.00 pp
    FII2.42%2.27%2.24%2.77%+0.53 pp
    DII5.22%5.19%5.21%3.06%-2.15 pp
    Public32.72%32.91%32.91%34.54%+1.63 pp

    Filed with NSE for Sept 2026: promoters 59.63%, public 40.37%

    Analysts & fund holdings

    Valuation vs Chemicals
    P/E5.5 vs 25.1
    Sector P/B3.02
    Beta1.24

    Who holds the shares, quarter by quarter

    Mutual funds 0.10% (-0.12 pp)
    Sept 25
    Nov 25
    Dec 25
    Mar 26
    Jun 26
    Sept 26
    • Promoters59.6%
    • Foreign institutions2.8%
    • Mutual funds0.1%
    • Insurance0.0%
    • Other domestic institutions3.0%
    • Retail20.4%
    • Others14.2%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    Motilal Oswal Nifty Microcap 250 Index Fund0.11%0.09%-0.19 pp
    Samco Multi Cap Fund0.03%0.29%+0.29 pp
    Groww Nifty Total Market Index Fund0.00%0.00%-0.01 pp
    Angel One Nifty Total Market Index Fund0.00%0.00%-0.01 pp
    Bandhan Nifty Total Market Index Fund0.00%0.00%-0.01 pp

    Scorecard

    Performance
    Avg
    Valuation
    Avg
    Growth
    Avg
    Profitability
    High
    Entry point
    Good
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Financial quality

    From consolidated statements to 31 Mar 2026.

    Computed

    Piotroski F-Score

    5 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — passed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — passed
    • Current ratio improving — failed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — passed
    • Asset turnover improving — passed
    Free cash flow
    -₹54 Cr
    FCF yield
    -3.0%
    Cash conversion
    2.63
    Accruals ratio
    -0.073
    Net debt
    ₹1,659 Cr
    Net debt / equity
    0.57
    EV / sales
    0.42
    PEG
    0.15
    Capex intensity
    8.4%
    Revenue CAGR
    7.8%
    Profit CAGR
    35.7%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Corporate actions

    • other
      Not available — not reported in this filing

      Demerger

      2 Sept 2026
      ex-date
    • dividend
      ₹7.50

      Interim Dividend - Rs 7.50 Per Share

      23 Mar 2026
      ex-date
    • dividend
      ₹5.00

      Dividend - Rs 5 Per Share

      23 Sept 2025
      ex-date
    • split
      Not available — not reported in this filing

      Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share

      12 Aug 2025
      ex-date
    • dividend
      ₹8.00

      Annual General Meeting/Dividend - Rs 8 Per Share

      21 Aug 2024
      ex-date
    • dividend
      ₹7.50

      Annual General Meeting/Dividend - Rs 7.50 Per Share

      5 Sept 2023
      ex-date
    • dividend
      ₹7.50

      Annual General Meeting/Dividend - Rs 7.50 Per Share

      29 Aug 2022
      ex-date
    • dividend
      ₹6.00

      Annual General Meeting/Dividend - Rs 6 Per Share

      16 Sept 2021
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      16 Sept 2020
      ex-date
    • dividend
      ₹6.00

      Interim Dividend - Rs 6 Per Share

      11 Mar 2020
      ex-date
    • dividend
      ₹6.00

      Annual General Meeting/Dividend - Rs 6 Per Share

      13 Aug 2019
      ex-date
    • dividend
      ₹4.00

      Annual General Meeting/Dividend- Rs 4 Per Share

      26 Jul 2018
      ex-date
    • dividend
      Not available — not reported in this filing

      Annual General Meeting/Dividend - Re 1/- Per Share

      23 Aug 2017
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      16 Sept 2016
      ex-date
    • other
      Not available — not reported in this filing

      Annual General Meeting

      21 Aug 2015
      ex-date
    • dividend
      Not available — not reported in this filing

      Annual General Meeting / Final Dividend - Re 1/- Per Share

      8 Sept 2014
      ex-date
    • dividend
      ₹2.00

      Annual General Meeting / Final Dividend - Rs 2/- Per Share

      5 Sept 2013
      ex-date
    • dividend
      ₹4.00

      Interim Dividend Rs 4 Per Share

      14 Mar 2013
      ex-date
    • dividend
      ₹3.00

      Annual General Meeting/Dividend Rs 3 Per Share

      3 Sept 2012
      ex-date
    • dividend
      ₹1.50

      Annual General Meeting/Dividend Rs 1.50 Per Share

      13 Sept 2011
      ex-date

    Company announcements

    Company Update
    Intimation Of GST Order

    Please find attached

    Company Update
    Clarification On Movement In Price

    Please find attached

    Company UpdatePrice-sensitive
    Clarification sought from India Glycols Ltd

    The Exchange has sought clarification from India Glycols Ltd on October 08, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....

    Company Update
    Apportionment Of Cost Of Acquisition Of Equity Shares Of India Glycols Limited ('Demerged Company'/'The Company'), Ennature Bio Pharma Limited ('Resulting Company 1') And IGL Spirits Limited ('Resulting Company 2') Pursuant To Scheme Of Arrangement Amongst The Company, Resulting Company 1 And Resulting Company 2 And Their Respective Shareholders ('Scheme'/'Scheme Of Arrangement')

    Please find attached.

    Company Update
    Update On Analyst / Institutional Investor Meetings.

    Please find attached.

    Company Update
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find attached

    Company Update
    Intimation Of Schedule Of Analyst / Institutional Investor Meeting.

    Please find attached.

    Insider Trading / SAST
    Closure of Trading Window

    Please find attached.

    Company Update
    Intimation Of Schedule Of Analyst / Institutional Investor Meeting.

    Please find attached.

    Company Update
    Intimation Of Schedule Of Plant Visit By Investors/Analysts.

    Please find attached.

    Company Update
    Material Update In Connection With Ennature Bio Pharma Limited

    Please find attached

    Company Update
    Material Update In Connection With IGL Spirits Limited

    Please find attached

    Company Update
    Intimation Of Schedule Of Analyst / Institutional Investor Meeting.

    Please find attached

    Company Update
    Material Update In Connection With Ennature Bio Pharma Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.

    Please find attached

    Company Update
    Material Update In Connection With IGL Spirits Limited With Reference To Observation Letter No. NSE/LIST/48932 Dated 17Th November, 2025 And No. DCS/AMAL/TS/R37/3905/2025-26 Dated 19Th November, 2025 ("Observation Letters"), Issued By The National Stock Exchange Of India Limited And BSE Limited (Collectively The "Stock Exchanges"), Respectively, Received In Relation To The Scheme Of Arrangement.

    Please find attached

    Filed with BSE (scrip 500201); the last 45 days. Documents open at bseindia.com.

    Documents

    Earnings calls

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 14 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    India Glycols: common questions

    Answered from the figures on this page.

    India Glycols last traded at ₹271.75 (NSE, as of 18 Nov 2026). The last session moved it down 1.20%.

    India Glycols is valued at about ₹1,821 crore (NSE, as of 18 Nov 2026).

    India Glycols trades at a price-to-earnings ratio of 5.50 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    India Glycols has traded between ₹217.00 and ₹1,222.00 over the past 52 weeks, to 18 Nov 2026. It is currently 5% of the way up that range.

    India Glycols (INDIAGLYCO) is classified under FMCG on this site's screener.